HITS Inc.

A Seoul drug discovery company whose cloud platform pairs physics-based simulation with AI for binding prediction, screening, and molecule design.

Location: Seoul, South Korea

1 model(1 Protein, 1 Small molecule)

Models (1)

Northeastern University / Broad Institute / KAIST / EPFL / HITS Inc.

Released August 2, 2026

———

Enzyme-substrate specificity prediction by end-to-end co-folding, with no predefined binding pocket. AUROC 0.766 on unseen enzymes and substrates.

ProteinSmall molecule